TickerFacts.

Biomerica Inc (BMRA): Shareholders' Equity

Annual figures by period end, from SEC filings.

$2.63M
As of 2026-05-31
-39.2%
3-year compound annual growth
-22.2%
5-year compound annual growth
-6.6%
10-year compound annual growth
$14.21M2011-05-31: $4.33M2012-05-31: $4.98M2013-05-31: $5.83M2014-05-31: $5.91M2015-05-31: $5.60M2016-05-31: $5.22M2017-05-31: $4.49M2018-05-31: $4.33M2019-05-31: $3.98M2020-05-31: $14.21M2021-05-31: $9.23M2022-05-31: $8.32M2023-05-31: $11.72M2024-05-31: $6.59M2025-05-31: $4.11M2026-05-31: $2.63M$2.63M
2011-05-31 Shareholders' Equity (USD) 2026-05-31
Period endedShareholders' EquityChange YoYSource filing
2026-05-31$2.63M-35.9%2026-08-31, Balance as of period end
2025-05-31$4.11M-37.7%2026-08-31, Balance as of period end
2024-05-31$6.59M-43.8%2025-08-29, Balance as of period end
2023-05-31$11.72M+40.8%2024-08-28, Balance as of period end
2022-05-31$8.32M-9.8%2023-08-25, Balance as of period end
2021-05-31$9.23M-35.1%2022-08-29, Balance as of period end
2020-05-31$14.21M+257.0%2021-10-14, Balance as of period end
2019-05-31$3.98M-8.0%2020-08-31, Balance as of period end
2018-05-31$4.33M-3.6%2019-08-29, Balance as of period end
2017-05-31$4.49M-14.0%2018-08-29, Balance as of period end
2016-05-31$5.22M-6.8%2017-08-29, Balance as of period end
2015-05-31$5.60M-5.3%2016-08-29, Balance as of period end
2014-05-31$5.91M+1.4%2015-08-31, Balance as of period end
2013-05-31$5.83M+17.2%2014-08-29, Balance as of period end
2012-05-31$4.98M+15.0%2013-08-29, Balance as of period end
2011-05-31$4.33Mn/a2012-08-29, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Biomerica Inc (BMRA)2026-05-31$2.63M-35.9%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31-$31.46Mn/m
Anbio Biotechnology (NNNN)2025-12-31$30.16M+75.4%
Aspira Women's Health Inc. (AWHL)2025-12-31-$6.93Mn/m
Volitionrx Ltd (VNRX)2025-12-31-$34.25Mn/m
Celldex Therapeutics, Inc. (CLDX)2025-12-31$527.16M-29.4%
Immucell Corp (ICCC)2025-12-31$27.06M-1.7%
Alpha Teknova, Inc. (TKNO)2025-12-31$68.78M-16.5%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$671.39M-23.0%

Compare BMRA, IMDX, NNNN, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗